Abstract
Ulcerative colitis (UC) is an intestinal inflammatory disease characterised by the loss of intestinal crypts, edema, mucosal ulceration, and infiltration of inflammatory cells in the mucosa. The current study aimed to investigate the protective and therapeutic effects of sinigrin and underlying mechanisms in a dextran sulfate sodium (DSS)-induced mouse model of ulcerative colitis. DSS-induced colitis models were used to demonstrate sinigrin’s therapeutic/protective action. Mice were orally administered with sinigrin (15 mg/kg or 30 mg/kg) for a period of 12 days in both prophylactic and therapeutic models. Animal weights, stool consistency, and bleeding parameters were measured throughout the experimental period. After the experimental period, colon lengths were measured, and colon tissues were harvested to determine the levels of oxidative stress–inducing factors (nitrates and MDA levels) and anti-oxidant components (GSH, SOD, and catalase). Furthermore, gene expression analysis, IL-17 levels, and inflammatory marker expressions were measured using RT-qPCR, ELISA, and immunohistochemical methods respectively. Furthermore, histopathological observations and elucidation of the mechanism of action were determined using H&E analysis and Western blot analysis. Sinigrin treatment (in both prophylactic and therapeutic models) significantly mitigated the DSS-induced body weight loss, attenuated the colon length shrinkage, and improved the disease index score (p < 0.001). Further results revealed that sinigrin’s protective/therapeutic effect is associated with a significant attenuation of pro‑inflammatory cytokine production (p < 0.001), reversing the anti-oxidant enzyme levels (p < 0.001) and substantial improvement (2 folds) of the disruption of the colonic morphology in colon tissues compared to DSS control. Immunohistochemical analysis showed that sinigrin treatment remarkably reduced the DSS-induced myeloperoxidase, neutrophil elastase, and CD68 expression in colon tissues. Additionally, sinigrin successfully abrogated the DSS-induced IL-17 levels (p < 0.001) and improved the colonic barrier in colon tissues. Overall, these results demonstrated that sinigrin exerts protective and therapeutic effects on DSS‑induced colitis, by enhancing the anti-oxidant enzymes and suppressing the intestinal inflammatory cascade of markers by regulating the MAPK pathway.
Data Availability
All data generated or analysed during this study are included in this manuscript file (and its supplementary information files).
References
de Oliveira, D.E., R. Santos, G. DA Silva Cardoso, L. Da Costa Lima, M.L. De Sousa Cavalcante, M.S. Silva, A.K.M. Cavalcante, J.S. Severo, F.B. De Melo Sousa, G. Pacheco, E.H.P. Alves, L.M.S Nobre, J.V.R Medeiros, R.C. Lima-Junior, A.A Dos Santos and Tolentino, M. 2021. l-Glutamine and physical exercise prevent intestinal inflammation and oxidative stress without improving gastric dysmotility in rats with ulcerative colitis. Inflammation 44:617–632. https://doi.org/10.1007/s10753-020-01361-3.
Barros, V., J.S. Severo, P.H.M. Mendes, A.C.A. da Silva, K.B.V. de Oliveira, J.M.L. Parente, M.M. Lima, E.M.M. Neto, and AGUIAR DOS SANTOS, A. & TOLENTINO, M. 2021. Effect of dietary interventions on inflammatory biomarkers of inflammatory bowel diseases: A systematic review of clinical trials. Nutrition 91–92. https://doi.org/10.1016/j.nut.2021.111457.
Olivera, P., S. Danese, L. Pouillon, S. Bonovas, and L. Peyrin-Biroulet. 2019. Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence. Digestive and Liver Disease 51: 327–334. https://doi.org/10.1016/j.dld.2018.11.002.
M’KOMA, A. E. 2013. Inflammatory bowel disease: An expanding global health problem. Clinical Medicine Insights Gastroenterology 6: 33–47. https://doi.org/10.4137/CGast.S12731.
RAY, G. 2016. Inflammatory bowel disease in India - past, present and future. World Journal of Gastroenterology 22: 8123–8136. https://doi.org/10.3748/wjg.v22.i36.8123.
Loftus, C.G., E.V. Loftus J.R. Harmsen, W.S. Zinsmeister, A.R. Tremaine, W.J, Melton, L.J. 3RD & Sandborn, W.J. 2007. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflammatory Bowel Diseases 13:254–261.https://doi.org/10.1002/ibd.20029
Patel, D.N., C.A. King, S.R. Bailey, J.W. Holt, K. Venkatachalam, A. Agrawal, A.J. Valente, and B. Chandrasekar. 2007. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. Journal of Biological Chemistry 282: 27229–27238. https://doi.org/10.1074/jbc.M703250200.
Fujishima, S., A.R. Hoffman, A. R., T, Vu, K.J. Kim, H. Zheng, D. Daniel, Y. KIM, E. Wallace, E.F. J.W. Larrick, T.A and T.A. T. Raffin.1993. Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-α, and IL-1β. 154:478–485. https://doi.org/10.1002/jcp.1041540305.
Wright, H.L., R.J. Moots, and S.W. Edwards. 2014. The multifactorial role of neutrophils in rheumatoid arthritis. Nature Reviews Rheumatology 10: 593–601. https://doi.org/10.1038/nrrheum.2014.80.
Metzler, K.D., T.A. Fuchs, W.M. Nauseef, D. Reumaux, J. Roesler, I. Schulze, V. Wahn, V. Papayannopoulos, and A. Zychlinsky. 2011. Myeloperoxidase is required for neutrophil extracellular trap formation: Implications for innate immunity. Blood 117: 953–959. https://doi.org/10.1182/blood-2010-06-290171%JBlood.
Gunn, M.D., N.A. Nelken, X. Liao, and L.T. Williams. 1997. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. The Journal of Immunology 158: 376–383.
Deshmane, S.L., S. Kremlev, S. Amini, and B.E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): An overview. Journal of Interferon and Cytokine Research 29: 313–326. https://doi.org/10.1089/jir.2008.0027.
Nayar, S., and J.H. Cho. 2021. From single-target to cellular niche targeting in Crohn’s disease: Intercepting bad communications. eBioMedicine 74. https://doi.org/10.1016/j.ebiom.2021.103690.
Chu, S., W. Liu, Y. Lu, M. Yan, Y. Guo, N. Chang, M. Jiang, and G. Bai. 2020. Sinigrin enhanced antiasthmatic effects of beta adrenergic receptors agonists by regulating cAMP-mediated pathways. Frontiers in Pharmacology 11: 723. https://doi.org/10.3389/fphar.2020.00723.
Jie, M., W.M. Cheung, V. Yu, Y. Zhou, P.H. Tong, and J.W. Ho. 2014. Anti-proliferative activities of sinigrin on carcinogen-induced hepatotoxicity in rats. PLoS One1 9. https://doi.org/10.1371/journal.pone.0110145.
Lee, H.W., C.G. Lee, D.K. Rhee, S.H. Um, and S. Pyo. 2017. Sinigrin inhibits production of inflammatory mediators by suppressing NF-κB/MAPK pathways or NLRP3 inflammasome activation in macrophages. International Immunopharmacology 45: 163–173. https://doi.org/10.1016/j.intimp.2017.01.032.
Abbas, Q., M. Hassan, H. Raza, S.J. Kim, K.W. Chung, G.H. Kim, and S.Y. Seo. 2017. In vitro, in vivo and in silico anti-hyperglycemic inhibition by sinigrin. Asian Pacific Journal of Tropical Medicine 10: 372–379. https://doi.org/10.1016/j.apjtm.2017.03.019.
Mazumder, A., A. Dwivedi, and J. du Plessis. 2016. Sinigrin and its therapeutic benefits. Molecules 21: 416. https://doi.org/10.3390/molecules21040416.
Medicherla, K., A. Ketkar, B.D. Sahu, G. Sudhakar, and R. Sistla. 2016. Rosmarinus officinalis L. extract ameliorates intestinal inflammation through MAPKs/NF-κB signaling in a murine model of acute experimental colitis. Food & Function 7: 3233–3243. https://doi.org/10.1039/c6fo00244g.
Sharma, N., T.B. Shaikh, A. Eedara, M. Kuncha, R. Sistla, and S.B. Andugulapati. 2022. Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway. European Journal of Pharmacology 937. https://doi.org/10.1016/j.ejphar.2022.175366.
Sangaraju, R., N. Nalban, S. Alavala, V. Rajendran, M.K. Jerald, and R. Sistla. 2019. Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice. Inflammation Research 68: 691–704. https://doi.org/10.1007/s00011-019-01252-w.
Koneru, M., B.D. Sahu, J.M. Kumar, M. Kuncha, A. Kadari, E.K. Kilari, and R. Sistla. 2016. Fisetin protects liver from binge alcohol-induced toxicity by mechanisms including inhibition of matrix metalloproteinases (MMPs) and oxidative stress. Journal of Functional Foods 22: 588–601. https://doi.org/10.1016/j.jff.2016.02.019.
Wu, C., H. Yang, C. Han, Q. Wang, H. Zhang, T. Huang, W. Mao, C. Tang, W. Zhao, Z. Zhu, J. Xu, and W. Yang. 2021. Quyu Shengxin decoction alleviates DSS-induced ulcerative colitis in mice by suppressing RIP1/RIP3/NLRP3 signalling. Evidence-Based Complementary and Alternative Medicine 2021: 6682233. https://doi.org/10.1155/2021/6682233.
Tirunavalli, S.K., K. Gourishetti, R.S.S. Kotipalli, M. Kuncha, M. Kathirvel, R. Kaur, M.K. Jerald, R. Sistla, and S.B. Andugulapati. 2021. Dehydrozingerone ameliorates lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-κB pathway. Phytomedicine 92. https://doi.org/10.1016/j.phymed.2021.153729.
Andugulapati, S.B., K. Gourishetti, S.K. Tirunavalli, T.B. Shaikh, and R. Sistla. 2020. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine 78. https://doi.org/10.1016/j.phymed.2020.153298.
Coccia, M., O.J. Harrison, C. Schiering, M.J. Asquith, B. Becher, F. Powrie, and K.J. Maloy. 2012. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells. Journal of Experimental Medicine 209: 1595–1609. https://doi.org/10.1084/jem.20111453%JJournalofExperimentalMedicine.
Zhang, Z., M. Zheng, J. Bindas, P. Schwarzenberger, and J.K. Kolls. 2006. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflammatory Bowel Diseases 12: 382–388. https://doi.org/10.1097/01.Mib.0000218764.06959.91.
Lee, Y.J., J.Y. Han, C.G. Lee, K. Heo, S.I. Park, Y.S. Park, J.S. Kim, K.M. Yang, K.-J. Lee, T.-H. Kim, M.H. Rhee, and S.D. Kim. 2014b. Korean Red Ginseng saponin fraction modulates radiation effects on lipopolysaccharide-stimulated nitric oxide production in RAW264.7 macrophage cells. Journal of Ginseng Research 38: 208–214. https://doi.org/10.1016/j.jgr.2014.02.001.
Meier, J., and A. Sturm. 2011. Current treatment of ulcerative colitis. World Journal of Gastroenterology 17: 3204–3212. https://doi.org/10.3748/wjg.v17.i27.3204.
Eichele, D.D., and K.K. Kharbanda. 2017. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World journal of gastroenterology 23: 6016–6029. https://doi.org/10.3748/wjg.v23.i33.6016.
Sánchez De Medina, F., Martínez-Augustin, O., González, R., Ballester, I., Nieto, A., Gálvez, J. & Zarzuelo, A. 2004. Induction of alkaline phosphatase in the inflamed intestine: A novel pharmacological target for inflammatory bowel disease. Biochemical Pharmacology 68: 2317–2326. https://doi.org/10.1016/j.bcp.2004.07.045.
Tian, T., Z. Wang, and J. Zhang. 2017. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxidative Medicine and Cellular Longevity 2017: 4535194. https://doi.org/10.1155/2017/4535194.
Mo, J., J. Ni, M. Zhang, Y. Xu, Y. Li, N. Karim, and W. Chen. 2022. Mulberry anthocyanins ameliorate DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. 11: 1674.
Mei, Y., Z. Wang, Y. Zhang, T. Wan, J. Xue, W. He, Y. Luo, Y. Xu, X. Bai, Q. Wang, and Y. Huang. 2019. FA-97, a new synthetic caffeic acid phenethyl ester derivative, ameliorates DSS-induced colitis against oxidative stress by activating Nrf2/HO-1 pathway. Frontiers in Immunology 10: 2969. https://doi.org/10.3389/fimmu.2019.02969.
Cong C, X Yuan, Y Hu, W Chen, Y Wang, and L Tao.2021. Sinigrin attenuates angiotensin II-induced kidney injury by inactivating nuclear factor-κB and extracellular signal-regulated kinase signaling in vivo and in vitro International Journal of Molecular Medicine 48 https://doi.org/10.3892/ijmm.2021.4994
Kiesler, P., I.J. Fuss, and W. Strober. 2015. Experimental models of inflammatory bowel diseases. Cellular and Molecular Gastroenterology and Hepatology 1: 154–170. https://doi.org/10.1016/j.jcmgh.2015.01.006.
Wirtz, S., C. Neufert, B. Weigmann, and M.F. Neurath. 2007. Chemically induced mouse models of intestinal inflammation. Nature Protocols 2: 541–546. https://doi.org/10.1038/nprot.2007.41.
SARTOR, R. B. 2006. Mechanisms of disease: Pathogenesis of Crohn’s disease and ulcerative colitis. Nature Clinical Practice. Gastroenterology & Hepatology 3: 390–407. https://doi.org/10.1038/ncpgasthep0528.
Geremia, A., P. Biancheri, P. Allan, G.R. Corazza, and A. di Sabatino. 2014. Innate and adaptive immunity in inflammatory bowel disease. Autoimmunity Reviews 13: 3–10. https://doi.org/10.1016/j.autrev.2013.06.004.
Lee, H.W. and Lee, K.R. 2015. Effect of Sinigrin on vascular cell adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells via downregulation of NF-κB signaling pathways. 29:59315. https://doi.org/10.1096/fasebj.29.1_supplement.593.15.
Ito, R., M. Kita, M. Shin-Ya, T. Kishida, A. Urano, R. Takada, J. Sakagami, J. Imanishi, Y. Iwakura, T. Okanoue, T. Yoshikawa, K. Kataoka, and O. Mazda. 2008. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochemical and Biophysical Research Communications 377: 12–16. https://doi.org/10.1016/j.bbrc.2008.09.019.
Papayannopoulos, V., K.D. Metzler, A. Hakkim, and A. Zychlinsky. 2010. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. Journal of Cell Biology 191: 677–691. https://doi.org/10.1083/jcb.201006052%JJournalofCellBiology.
Luther, S.A., and J.G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nature Immunology 2: 102–107. https://doi.org/10.1038/84205.
Khan, W.I., Y. Motomura, H. Wang, R.T. El-Sharkawy, E.F. Verdu, M. Verma-Gandhu, B.J. Rollins, and S.M. Collins. 2006. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 291: G803–G811. https://doi.org/10.1152/ajpgi.00069.2006.
Chen, L., H. Deng, H. Cui, J. Fang, Z. Zuo, J. Deng, Y. Li, X. Wang, and L. Zhao. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9: 7204–7218. https://doi.org/10.18632/oncotarget.23208.
Broom, O.J., B. Widjaya, J. Troelsen, J. Olsen, and O.H. Nielsen. 2009. Mitogen activated protein kinases: A role in inflammatory bowel disease? Clinical and Experimental Immunology 158: 272–280. https://doi.org/10.1111/j.1365-2249.2009.04033.x.
Bachstetter, A.D., and L.J. van Eldik. 2010. The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS. Aging & Disease 1: 199–211.
Hommes, D., B. van den Blink, T. Plasse, J. Bartelsman, C. Xu, B. Macpherson, G. Tytgat, M. Peppelenbosch, and S. van Deventer. 2002. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn’s disease. Gastroenterology 122: 7–14. https://doi.org/10.1053/gast.2002.30770.
Schreiber, S., B. Feagan, G. D’Haens, J.F. Colombel, K. Geboes, M. Yurcov, V. Isakov, O. Golovenko, C.N. Bernstein, D. Ludwig, T. Winter, U. Meier, C. Yong, and J. Steffgen. 2006. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: A randomized, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology 4: 325–334. https://doi.org/10.1016/j.cgh.2005.11.013.
Hollenbach, E., M. Neumann, M. Vieth, A. Roessner, P. Malfertheiner, and M. Naumann. 2004. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. The FASEB Journal 18: 1550–1552. https://doi.org/10.1096/fj.04-1642fje.
Waetzig, G.H., D. Seegert, P. Rosenstiel, S. Nikolaus, and S. Schreiber. 2002. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. The Journal of Immunology 168: 5342–5351. https://doi.org/10.4049/jimmunol.168.10.5342.
Dahan, S., G. Roda, D. Pinn, F. Roth-Walter, O. Kamalu, A.P. Martin, and L. Mayer. 2008. Epithelial: Lamina propria lymphocyte interactions promote epithelial cell differentiation. Gastroenterology 134: 192–203. https://doi.org/10.1053/j.gastro.2007.10.022.
Lee, H., C. Lee, J. Kim, and Pyo, S. 2014a. The inhibitory effect of sinigrin on the production of inflammatory mediators induced by lipopolysaccharide in RAW 264.7 macrophages (1056.5). 28:1056.5. https://doi.org/10.1096/fasebj.28.1_supplement.1056.5.
Garat, C., and W.P. Arend. 2003. Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. Cytokine 23: 31–40. https://doi.org/10.1016/s1043-4666(03)00182-0.
Acknowledgements
Authors thank the Director, CSIR-IICT, Hyderabad, India, for providing the facilities and funding necessary for the conducting of this work. CSIR-IICT manuscript communication number: IICT/Pubs./2022/214.
Funding
Used internal funds of the institute. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
All data generated or analyzed during this study are included in this manuscript file (and its supplementary information files).
Author information
Authors and Affiliations
Contributions
Conceptualization: S.R.K, S.B.A, methodology: R. S.K, S.K.T, A.S.B, B.D.S; Western blot analysis and immunohistochemistry: S.K.T, anti-oxidant assays: R.S.K, In vivo experiments: M.K, R.S.K, A.B.P, histopathology: M.K.J, A.S.B; manuscript writing—review and editing: S.B.A, and S. R. K.; funding acquisition: S.R. K.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kotipalli, R.S.S., Tirunavalli, S.K., Pote, A.B. et al. Sinigrin Attenuates the Dextran Sulfate Sodium-induced Colitis in Mice by Modulating the MAPK Pathway. Inflammation 46, 787–807 (2023). https://doi.org/10.1007/s10753-022-01780-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-022-01780-4